BioPharm America – AI Applications.

Innovations, Advancements & Collaborations.

  • 21 September, 2020 - 24 September, 2020
  • 9:00 am - 3:00 pm

(The organizers of the event provided the content below.)

Our 2020 agenda provided case studies that will give you the opportunity to learn how to improve R&D productivity, expedite timelines & identify better drug candidates from target identification right through to post market.

Program Highlights

• Plenary from the Global Head of Emerging Technologies and Digital Health Partnerships at Takeda on What AI Can and Will Solve in the next 5-10 years
• Panel on What does Precision Medicine Actually Mean and How AI/ML Can Impact it – moderated by the Chief Strategy Officer at Blackthorn Therapeutics
• Plenary – What are the big questions AI can help answer and what’s holding us back from the Machine Learning & AI Technical Lead at Pfizer and Harvard Lecturer
• Presentation on AI and Genomic Approaches to Diagnostics in Rare-Disease Space from the Vice President of Data Sciences, Genomics and Bioinformatics at Alexion Pharmaceuticals
• Case Study: Drug Discovery Models to Prioritize Pathways and Targets for Parkinson’s Disease from the COO at Vincere Bio
• AI in Hospitals for Operational Excellence, Clinical Decision Support and Predicting Treatment Outcomes from the CRIO at Nationwide Children’s Hospital

What’s New for 2020

The focus isn’t just on discovery this year, we’ve added more to cover business and healthcare topics
• Drug Discovery and Development
• Clinical Trials and Clinical Development
• Imaging and Radiology
• Data Foundations for Enabling AI and ML
• Healthcare Delivery, Hospitals and Precision Medicine
• Privacy, IP and Data Consent

Contact Us.

18